Aarti Drugs Limited (BOM: 524348)
India
· Delayed Price · Currency is INR 509.55
-0.30 (-0.06%)
At close: Oct 11, 2024
Aarti Drugs Revenue
Aarti Drugs had revenue of 5.55B INR in the quarter ending June 30, 2024, a decrease of -16.00%. This brings the company's revenue in the last twelve months to 24.23B, down -12.06% year-over-year. In the fiscal year ending March 31, 2024, Aarti Drugs had annual revenue of 25.29B, down -6.90%.
Revenue (ttm)
24.23B
Revenue Growth
-12.06%
P/S Ratio
1.93
Revenue / Employee
22.77M
Employees
1,064
Market Cap
46.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 25.29B | -1.87B | -6.90% |
| Mar 31, 2023 | 27.16B | 2.27B | 9.14% |
| Mar 31, 2022 | 24.89B | 3.34B | 15.49% |
| Mar 31, 2021 | 21.55B | 3.49B | 19.31% |
| Mar 31, 2020 | 18.06B | 2.45B | 15.71% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAarti Drugs News
- 9 days ago - Aarti Drugs shares surge over 2% after arm gets GMP certificate from UK MHRA - Business Upturn
- 10 days ago - Aarti Drugs’ subsidiary Pinnacle Life Science receives GMP certificate from UK MHRA - Business Upturn
- 4 weeks ago - Aarti Drugs Buyback Opens Today, Set to Close on 18th September 2024 - Business Upturn
- 6 weeks ago - Aarti Drugs announces share buyback at 60% premium - Business Upturn
- 7 weeks ago - Aarti Drugs shares surge 10% ahead of board meeting on sixth buyback plan - Business Upturn